Patent Assignment
Reel/Frame 018338/0962
Release
Recorded: 2006-09-26
Pages: 4
Assignor
LASALLE BANK NATIONAL ASSOCIATION
Executed: 2006-09-18
Assignee
FIRST HORIZON PHARMACEUTICAL CORPORATION
5 CONCOURSE PARKWAY, SUITE 1800, ATLANTA, GEORGIA, 30328-5350
Covered Properties
(5)
Heterocyclic Compounds and Their Pharmaceutical Formulation
Patent:
5,091,395 →
Application:
07/270,487 →
Derivatives of 1,2,3,4-Tetrahydro-9-Acrisinamine
Patent:
4,999,430 →
Application:
07/387,722 →
Compositions with Enhanced Penetration
Patent:
5,019,395 →
Application:
07/391,808 →
Controlled Release Tacrine Druge Delivery Systems and Methods for Preparing Same
Patent:
5,576,022 →
Application:
08/422,019 →
Tannate Compositions and Methods of Treatment
Patent:
6,509,492 →
Application:
09/952,711 →
Related Assignments
(15)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignors Interest.
Aug 30, 1989
From: KESTER, JEFFREY A.; MOOS, WALTER H.; THOMAS, ANTHONY J.
To: WARNER-LAMBERT COMPANY, A CORP. OF DE.
Reel/Frame 005124/0901 →
Assignment of Assignors Interest.
Nov 6, 1989
From: MAHJOUR, MAJID; MAUSER, BERNADETTE; RASHIDBAIGI, ZAHRA; LINN, EDWARDS E.
To: WARNER-LAMBERT COMPANY, A CORP. OF DE
Reel/Frame 005204/0262 →
Assignment of Assignors Interest.
Dec 18, 1989
From: KESTER, JEFFREY A.; MOOS, WALTER H.; THOMAS, ANTHONY J.
To: WARNER-LAMBERT COMPANY, A CORP. OF DE.
Reel/Frame 005197/0668 →
Assignment of Assignor's Interest
Mar 29, 2001
From: WARNER-LAMBERT COMPANY
To: FIRST HORIZON PHARMACEUTICAL CORPORATION
Reel/Frame 011658/0328 →
Assignment of Assignor's Interest
Mar 29, 2001
From: WARNER-LAMBERT COMPANY
To: FIRST HORIZON PHARMACEUTICAL CORPORATION
Reel/Frame 011658/0333 →
Assignment of Assignor's Interest
Feb 8, 2002
From: VENKATARAMAN, BALAJI
To: FIRST HORIZON PHARMACEUTICAL CORPORATION
Reel/Frame 012593/0537 →
Security Agreement
Apr 1, 2002
From: FIRST HORIZON PHARMACEUTICAL CORPORATION
To: BANKERS TRUST COMPANY
Reel/Frame 012762/0875 →
Please Note That U.S. Patent No. 5019395 Was Previously Erroneously Recorded as U.S Patent No. 5091395, on Reel 011658 Frame 0333 on March 29, 2001.
Jun 14, 2002
From: WARNER-LAMBERT COMPANY
To: FIRST HORIZON PHARMACEUTICAL CORPORATION
Reel/Frame 012991/0811 →
Release of Security Interest
Feb 11, 2003
From: DEUTSCHE BANK TRUST COMPANY AMERICAS (F/K/A BANKERS TRUST COMPANY)
To: FIRST HORIZON PHARMACEUTICAL CORPORATION
Reel/Frame 013791/0149 →
Security Interest
Feb 24, 2003
From: FIRST HORIZON PHARMACEUTICAL CORPORATION
To: LASALLE NATIONAL BANK ASSOCIATION
Reel/Frame 013774/0650 →
Security Interest
Jul 21, 2003
From: FIRST HORIZON PHARMACEUTICAL CORPORATION
To: LASALLE NATIONAL BANK ASSOCIATION
Reel/Frame 014289/0670 →
Change of Name
Jun 29, 2006
From: FIRST HORIZON PHARMACEUTICAL CORPORATION
To: SCIELE PHARMA, INC.
Reel/Frame 017858/0545 →
Security Agreement
Sep 25, 2006
From: SCIELE PHARMA, INC.
To: GMAC COMMERCIAL FINANCE LLC
Reel/Frame 018303/0896 →
Release of Security Interest
Apr 6, 2009
From: UBS AG, STAMFORD BRANCH
To: SCIELE PHARMA, INC.
Reel/Frame 022510/0181 →
Change of Name
Feb 23, 2010
From: SCIELE PHARMA, INC.
To: SHIONOGI PHARMA, INC.
Reel/Frame 023979/0193 →